1. Home
  2. RADX
  3. RADX News

Latest RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD (RADX) News on February 5, 2025

Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement
RADX

GlobeNewswire

a month ago

Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia
RADX

GlobeNewswire

a month ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial
RADX

GlobeNewswire

2 months ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Share on Social Networks: